Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce.
Joshua Peter VogelBritta TendalMichelle Therese GilesClare L WhiteheadWendy BurtonSamantha Paubrey ChakrabortySaskia CheyneTeena DowntonDavid Fraile NavarroGlenda GleesonAdrienne GordonJenny HuntJackie KitschkeSteven McDonaldNolan McDonnellPhilippa F MiddletonTanya MillardMelissa MuranoJeremy J N OatsRhiannon TateHeath WhiteJulian H ElliottVijay RoachCaroline S E Homernull nullPublished in: The Australian & New Zealand journal of obstetrics & gynaecology (2020)
To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.
Keyphrases
- coronavirus disease
- sars cov
- extracorporeal membrane oxygenation
- venous thromboembolism
- pregnant women
- healthcare
- palliative care
- clinical practice
- angiotensin converting enzyme
- mesenchymal stem cells
- acute respiratory distress syndrome
- intensive care unit
- low dose
- atrial fibrillation
- high dose
- physical activity
- quantum dots
- soft tissue
- mechanical ventilation
- sensitive detection